Related content

Hyporesponsiveness to Erythropoietin Therapy in Hemodialyzed Patients: Potential Role of Prohepcidin, Hepcidin, and Inflammation

By Malyszko Jolanta   Malyszko Jacek   Mysliwiec Michal  

Renal Failure, Vol. 31, Iss. 7, 2009-08 ,pp. : 544-548

Informa Healthcare

Access to resources Recommend Favorite

Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

By Post James   Wilkes Barry   Michelis Michael  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 719-723

Springer Publishing Company

Access to resources Recommend Favorite

Autotransfusion Supported by Erythropoietin Therapy in Transurethral Resection of the Prostate

By Goya Nobuyuki   Toda Fusako   Nishino Seiichi   Tokumoto Tadahiko   Iguchi Yasuhiro   Kobayashi Hiroshi   Ohshima Tadashi   Kihara Takeshi   Tanabe Kazunari   Yagisawa Takashi   Nakazawa Hayakazu   Toma Hiroshi   Fujii Hisaichi   Shimizu Masaru  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 6, 1998-12 ,pp. : 383-387

Informa Healthcare

Access to resources Recommend Favorite

Use of Erythropoietin as adjuvant therapy in nerve reconstruction

By Lohmeyer J.  

Langenbeck's Archives of Surgery, Vol. 393, Iss. 3, 2008-05 ,pp. : 317-323

Springer Publishing Company

Access to resources Recommend Favorite

Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion

By Ranjbar Moslem  

Clinical and Experimental Nephrology, Vol. 16, Iss. 4, 2012-08 ,pp. : 636-646

Springer Publishing Company

Access to resources Recommend Favorite